PMID- 26504855 OWN - NLM STAT- MEDLINE DCOM- 20160524 LR - 20181113 IS - 2314-7156 (Electronic) IS - 2314-8861 (Print) IS - 2314-7156 (Linking) VI - 2015 DP - 2015 TI - Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives. PG - 453046 LID - 10.1155/2015/453046 [doi] LID - 453046 AB - We performed a retrospective study of autoimmune conditions (ACs) in 235 hemochromatosis probands at diagnosis by analyzing age, sex, ACs, history of first-degree family members with ACs (FH), diabetes, heavy ethanol consumption, elevated serum ALT/AST, nonalcoholic fatty liver disease, viral hepatitis, cirrhosis, iron removed to achieve iron depletion (QFe), and positivity for human leukocyte antigen (HLA) haplotypes A ( *) 01, B ( *) 08; A ( *) 02, B ( *) 44; A ( *) 03, B ( *) 07; A ( *) 03, B ( *) 14; and A ( *) 29, B ( *) 44. There were 138 men (58.7%). Median followup was 19.6 y. One or more of 19 ACs were diagnosed in each of 35 probands (14.9%). Prevalences of Hashimoto's thyroiditis, rheumatoid arthritis, and ankylosing spondylitis were 8.1% (95% CI: [5.1, 12.5]), 1.7% [0.6, 4.6], and 0.0085 [0.0015, 0.0337], respectively. Eighteen probands (7.7%) had a FH. Eight probands with ACs had 9 family members with ACs. In a logistic regression, ACs were less likely in men (odds ratio (OR) 0.3 [0.1, 0.6]) and more likely in probands with a FH (OR 4.1 [1.4, 11.8]). Overall ACs risk was not significantly associated with QFe or HLA haplotypes. Estimated survival of probands with and without ACs did not differ significantly. We conclude that ACs are common in hemochromatosis probands, especially women and probands with a FH. FAU - Barton, James C AU - Barton JC AD - Southern Iron Disorders Center, Birmingham, AL 35209, USA ; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35209, USA. FAU - Barton, J Clayborn AU - Barton JC AD - Southern Iron Disorders Center, Birmingham, AL 35209, USA. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't DEP - 20151004 PL - Egypt TA - J Immunol Res JT - Journal of immunology research JID - 101627166 RN - 0 (Codon) RN - 0 (HFE protein, human) RN - 0 (HLA Antigens) RN - 0 (Hemochromatosis Protein) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Membrane Proteins) RN - 9007-73-2 (Ferritins) SB - IM MH - Adult MH - Amino Acid Substitution MH - Autoimmune Diseases/genetics/immunology MH - *Autoimmunity MH - Codon MH - Comorbidity MH - Disease Susceptibility MH - *Family MH - Female MH - Ferritins/blood/metabolism MH - HLA Antigens/genetics/immunology MH - Hemochromatosis/epidemiology/*genetics/*immunology/metabolism/mortality MH - Hemochromatosis Protein MH - Histocompatibility Antigens Class I/*genetics MH - *Homozygote MH - Humans MH - Kaplan-Meier Estimate MH - Male MH - Membrane Proteins/*genetics MH - Middle Aged MH - *Mutation MH - Prevalence MH - Prognosis MH - Retrospective Studies MH - Risk Factors PMC - PMC4609477 EDAT- 2015/10/28 06:00 MHDA- 2016/05/25 06:00 PMCR- 2015/10/04 CRDT- 2015/10/28 06:00 PHST- 2015/06/18 00:00 [received] PHST- 2015/08/02 00:00 [accepted] PHST- 2015/10/28 06:00 [entrez] PHST- 2015/10/28 06:00 [pubmed] PHST- 2016/05/25 06:00 [medline] PHST- 2015/10/04 00:00 [pmc-release] AID - 10.1155/2015/453046 [doi] PST - ppublish SO - J Immunol Res. 2015;2015:453046. doi: 10.1155/2015/453046. Epub 2015 Oct 4.